Stock Options - The total number of stock options available for grant under the stock option plan as of January 1, 2024, and December 31, 2024, is 101,688,167[4] - The total number of shares available for issuance under the stock option plan represents approximately 10.21% of the company's issued shares as of the date of the 2024 annual report[4]

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告之內容概不負責，對其準確性或 完整性亦不發表任何聲明，並明確表示，概不對因本公告全部或任何部分內容而產生或因倚賴該 等內容而引致的任何損失承擔任何責任。 （在香港註冊成立之有限公司） （股份代號：81） 二零二五年第三季度財務及業務回顧 於本季內，本集團於包頭、惠州及唐山合共新購得四塊土地，其應佔權益樓面面 積合計約達 519,300 平方米，需支付權益地價合計約人民幣 18.22 億元。於二零 二五年九月三十日，中海宏洋系列公司持有位於中國內地可建樓面面積共約為 13,267,200 平方米（其中，包括由聯營公司及合營公司持有，本集團應佔權益之 樓面面積約為 11,229,600 平方米）之土地儲備。 1 本集團保持對財務資源專業及穩健之財務管理，並會繼續密切關注外圍經濟形 勢、人民幣匯率波動、行業收併購機會及國家政策變化對業務運作所帶來的影響， 為股東帶來長遠最佳回報。 一般資料 本公告可能包含涉及風險和不確定因素的前瞻性陳述。公司股東及潛在投資者不 應過份依賴公司於本公告日的前瞻性陳述。此前瞻性陳述是基於本集團自有的資 料和其他我們相信可靠來源的資 ...

Stock Options - The total number of stock options available for grant under the stock option plan is 192,000,000 shares, representing 5% of the company's issued share capital as of December 31, 2024[3] - No stock options have been granted since the adoption of the stock option plan[3] Annual Report - The announcement should be read in conjunction with the 2024 annual report, and all other information in the annual report remains unchanged[4]

香港交易及結算所有限公司及香港聯合交易所有限公司對本公佈的內容概不負責，對其準確性或完整性亦不 發表任何聲明，並明確表示，概不對因本公佈全部或任何部份內容而產生或因倚賴該等內容而引致的任何損 失承擔任何責任。 業績摘要： 1 • 儘管本集團之投資物業及酒店業務表現穩健，本公司擁有人應佔淨虧損由上個財 政年度之 267,700,000港元增加至回顧年度之419,400,000港元。虧損增加之主要 原因為：(i)該等物業項目已將近全數售罄，令其銷售減少；及(ii)於回顧年度內投 資物業錄得公平值虧損，而上個財政年度則錄得投資物業公平值收益。該等增加 之虧損部分被行政費用、其他經營費用及融資成本改善所抵銷。 • 扣除投資物業公平值變動以及其他非現金及非經常性項目之影響，經調整除利 息、稅項、折舊及攤銷前盈利（「經調整EBITDA」）為416,300,000港元，較上個財 政年度減少46.8%，原因是現有項目銷售將近結束且符合預期。 • 租賃組合保持穩健，產生租金收入721,800,000港元，在充滿挑戰之市場環境下， 仍然維持相對穩定的出租率，較上個財政年度上升0.9%，此乃得益於較新落成的 物業的租金增長。 • ...

Financial Performance - For the fiscal year ending July 31, 2025, the company reported a revenue of HKD 779,608,000, a decrease of 33.3% compared to HKD 1,167,538,000 in the previous year[4] - The gross profit for the same period was HKD 377,754,000, down 16.3% from HKD 451,124,000 year-over-year[4] - The company recorded an operating profit of HKD 35,981,000, a significant recovery from an operating loss of HKD 434,787,000 in the prior year[4] - The net loss for the year was HKD 14,510,000, a substantial improvement compared to a net loss of HKD 525,729,000 in the previous year[4] - Total revenue for 2025 is projected to be HKD 808,930,000, a decrease from HKD 1,203,450,000 in 2024, representing a decline of approximately 32.8%[13] - The group reported a net loss of HKD 14,510,000 for 2025, compared to a net loss of HKD 525,729,000 in 2024, indicating an improvement in financial performance[13] - The total financing costs decreased to HKD 42,651,000 in 2025 from HKD 45,035,000 in 2024, representing a reduction of 5.3%[18] - The pre-tax loss before tax for 2025 was HKD 401,854,000, significantly lower than HKD 716,414,000 in 2024, indicating a 44% reduction in costs[19] Assets and Liabilities - Total current liabilities increased to HKD 1,151,437,000 from HKD 922,895,000, indicating a rise in financial obligations[6] - Cash and cash equivalents stood at HKD 482,525,000, up from HKD 354,272,000, reflecting improved liquidity[6] - The company's total non-current assets decreased to HKD 535,826,000 from HKD 746,911,000, indicating a reduction in long-term investments[6] - The total equity attributable to the owners of the company was HKD 67,401,000, down from HKD 118,473,000, showing a decline in shareholder value[7] - Total assets decreased from HKD 1,836,303,000 in 2024 to HKD 1,631,619,000 in 2025, a reduction of approximately 11.1%[14] - Total liabilities also decreased from HKD 1,788,225,000 in 2024 to HKD 1,596,522,000 in 2025, reflecting a decline of about 10.7%[14] - The net receivables from trade accounts decreased to HKD 97,207,000 in 2025 from HKD 191,195,000 in 2024, a decline of 49.3%[23] - The total contract liabilities increased to HKD 179,926,000 in 2025 from HKD 142,506,000 in 2024, reflecting a growth of 26.3%[27] Operational Strategies - The company has implemented plans to manage working capital and improve financial conditions, including obtaining legal opinions regarding loan repayments[9] - The group plans to continue implementing cost-saving measures and negotiate rent reductions or lease restructuring with landlords[12] - The group intends to sell several non-core assets to streamline operations and reduce operational costs[12] - The group is actively implementing cost optimization measures in cinema operations to enhance overall operational efficiency amid challenging market conditions[31] Revenue Breakdown - The media and entertainment segment generated revenue of HKD 287,897,000 in 2025, down from HKD 387,082,000 in 2024, a decrease of about 25.6%[13] - Revenue from external customers in Hong Kong for 2025 was HKD 593,900,000, down from HKD 769,348,000 in 2024, a decrease of approximately 22.8%[16] - The revenue from entertainment activities was HKD 182,259,000 in 2025, down 28.6% from HKD 255,119,000 in 2024[18] - Revenue from film and television programs dropped significantly by about 86.3%, primarily due to a lack of television program releases during the fiscal year[35] - The group's cinema operations saw a slight revenue increase of approximately 1.3%, attributed to the success of blockbuster films such as "破•地獄" and "哪吒之魔童鬧海"[36] - The film and television production and distribution segment reported revenue of HKD 46.6 million, a significant decrease from HKD 341 million in the previous year, with losses increasing to HKD 52 million from HKD 21.9 million[45] Shareholder Information - The company did not recommend any dividend for the year ending July 31, 2025, consistent with the previous year[28] - The annual general meeting will be held on December 19, 2025[55] - The annual report for the year ending July 31, 2025, will be published in mid-November 2025[55] - Shareholders must submit transfer documents by December 15, 2025, to attend and vote at the meeting[56] - The record date for attending and voting at the annual general meeting is December 15, 2025[56] Staffing and Management - The group employed approximately 390 staff members, a decrease from 470 in the previous year, while maintaining competitive salary levels and performance-based promotions[51] - The board of directors includes three executive directors and five independent non-executive directors[56] - The group actively engaged with investors through various communication channels to provide updates on operations and financial performance[52]

Financial Performance - For the first three quarters of 2025, the company's operating revenue was RMB 397 billion, representing a year-on-year increase of 0.6%[7] - The profit attributable to shareholders was RMB 30.8 billion, reflecting a year-on-year growth of 5.0%[7] - The EBITDA for the period was RMB 115.6 billion, with a year-on-year increase of 4.2%, resulting in an EBITDA margin of 31.6%[7][8] - Total operating revenue for the nine months ended September 30, 2025, was RMB 396,998 million, a slight increase from RMB 394,718 million in the same period of 2024, representing a growth of approximately 0.3%[16] - Net profit for the nine months ended September 30, 2025, reached RMB 30,771 million, compared to RMB 29,340 million in 2024, indicating an increase of about 4.9%[17] - The company reported a total of RMB 37,739 million in operating profit for the nine months ended September 30, 2025, compared to RMB 36,384 million in 2024, representing an increase of approximately 3.7%[16] - The pre-tax profit for the nine months ended September 30, 2025, was RMB 39,450 million, up 5% from RMB 37,712 million in 2024[19] User Growth and Traffic - The total number of mobile users reached 43.72 million, with a net increase of 1.27 million users during the period[6] - The number of 5G network users reached 29.24 million, with a net increase of 4.17 million users[6] - The total mobile internet traffic was 7,733.26 million TB, showing a year-on-year growth of 16.9%[9] Revenue Streams - The company's IDC revenue was RMB 27.5 billion, up 9.1% year-on-year, while intelligent revenue grew by 62.3%[10] Assets and Liabilities - Total assets as of September 30, 2025, were RMB 876.05 billion, an increase of 1.1% compared to the previous year[5] - Total assets as of September 30, 2025, amounted to RMB 876,049 million, up from RMB 866,625 million at the end of 2024, reflecting a growth of approximately 1.6%[15] - The company's total liabilities stood at RMB 410,815 million as of September 30, 2025, slightly up from RMB 410,073 million in 2024, showing a marginal increase of 0.2%[15] - The net current liabilities improved to RMB (106,612) million in 2025 from RMB (137,252) million in 2024, indicating a positive change in liquidity[15] - The total equity attributable to shareholders increased to RMB 458,123 million in 2025 from RMB 452,390 million in 2024, showing a growth of about 1.3%[15] Cash Flow and Expenditures - The company's cash and cash equivalents decreased to RMB 44,594 million in 2025 from RMB 82,207 million in 2024, a decline of approximately 45.4%[14] - The net cash generated from operating activities for the nine months ended September 30, 2025, was RMB 87,421 million, a decrease of 10% compared to RMB 97,316 million for the same period in 2024[18] - The company's capital expenditures for the nine months ended September 30, 2025, were RMB (44,810) million, down 23% from RMB (58,238) million in 2024[18] - The net cash used in investing activities was RMB (84,958) million, an increase of 23% compared to RMB (68,913) million in 2024[18] - The company reported a net cash outflow from financing activities of RMB (40,033) million, compared to RMB (36,080) million in 2024, indicating a 11% increase in cash outflow[18] - Cash and cash equivalents decreased by RMB 37,570 million during the nine months ended September 30, 2025, compared to a decrease of RMB 7,677 million in 2024[18] Dividends and Interest - The company paid dividends amounting to RMB (25,064) million, which is an increase of 17% from RMB (21,300) million in 2024[18] - The company experienced a net interest expense of RMB 1,563 million for the nine months ended September 30, 2025, compared to RMB 1,794 million in 2024[19] Strategic Initiatives - The company plans to fully implement a cloud transformation strategy, enhancing core capabilities and competitiveness[12]

Business Operations - The Group operates 120 retail pharmacies primarily located in Northeast China, with approximately 1,027 active distributors and 842 full-time staff[8]. - The Group has established 3 large-scale distribution logistics centers in Shijiazhuang, Harbin, and Jiamusi, enhancing its national distribution system[8]. - The main product categories include prescribed drugs, non-prescribed drugs, traditional Chinese medicine, and health care products, among others[9]. - The Group aims to expand its product mix by introducing more health care products based on its expertise in pharmaceutical retail and distribution[11]. - The Group is actively exploring online pharmacies, cross-border e-commerce, and influencer marketing as part of its "Internet+" strategy[12]. - The Group emphasizes the concept of "Specialization+" and "Platform+" to enhance its business model and cope with the "New Norm" in the real economy[12]. - The Group is focused on upgrading and digital transformation within the industry to maintain its competitive edge[12]. - The Group's strategy includes leveraging core advantages of branded products and expanding cooperation in this area[11]. - The Group is committed to developing the upstream ecological chain, including the construction of Chinese herbal medicine bases[11]. - The Group's vision is to become a leading international brand operator in the universal health industry[7]. Financial Performance - Revenue for the year ended June 30, 2025, was RMB 711.5 million, a decrease of 34.7% from RMB 1,089.0 million in 2024[20]. - Gross profit decreased by 37.0% to RMB 113.4 million from RMB 179.9 million[20]. - The company reported an operating loss of RMB 25.5 million, compared to a profit of RMB 0.1 million in the previous year[20]. - Basic loss per share was RMB (32.46) cents, down from RMB 0.62 cents in 2024, representing a decline of 33.08 cents[20]. - The current ratio improved to 1.3 times from 1.0 times, indicating better short-term financial health[20]. - Trade receivables turnover days increased to 33.4 days from 27.8 days, reflecting slower collection of receivables[20]. - The total number of stores as of June 30, 2025, was 120, with 83 stores closed during the year due to lower profitability[32]. - The company is focusing on optimizing its business model and improving operational efficiency in response to market changes[31]. - The Group's retail business revenue was RMB 197.9 million for the Year, representing a year-on-year decrease of 40.4%[60]. - The nationwide distribution business revenue was RMB 513.6 million, a year-on-year decrease of 32.1%[64]. - The Group operated a total of 223 branded products at the end of the Year, following a net reduction of 315 branded products[67]. - The Group had a total of 120 chain stores at the end of the Year, down from 203 in 2024[60]. - The distribution segment revenue decreased by 32.1% to RMB 513.6 million, while retail segment revenue fell by 40.4% to RMB 197.9 million[90]. Market Trends and Strategies - Future industry development is expected to focus on precision medicine, digital health, and the elderly care economy[29]. - The global GDP growth is predicted to slow down to about 2.3% in 2025, impacting operational strategies[29]. - The market size of China's healthcare industry is expected to reach RMB 29.1 trillion by 2030[44]. - The Group aims to enhance its strength and improve the product line-up through the development of integrated outpatient services[37]. - The Chinese government has prioritized the development of the traditional Chinese medicine (TCM) industry, introducing supportive policies to promote high-quality development[45]. - The application of artificial intelligence in disease diagnosis and health management has improved efficiency and accuracy in the healthcare sector[48]. - The PRC has accelerated the construction of the elderly care service system, enhancing service quality and management levels in 2024[50]. - Investment in preventive medicine has increased, focusing on vaccine research and health education to reduce disease occurrence[51]. - The demand for healthcare and elderly care services is continuously growing due to an aging population and increased health awareness[48]. Corporate Responsibility and Sustainability - The Group is committed to corporate responsibility, focusing on environmental, social, and governance aspects to enhance long-term competitiveness[38]. - The company is committed to enhancing sustainability practices and addressing climate impact through ambitious environmental goals[151]. - The company aims to create value for stakeholders through responsible operations, focusing on environmental, operational, and community factors[152]. - The company engages with various stakeholders, including government regulators and investors, to ensure compliance and transparency[156]. - The company actively participates in community welfare projects and addresses social responsibilities[156]. - The Group's emission indicators for the year ended June 30, 2024, include 301.6 kg of nitrogen oxides (NOx) and 90,188.9 kg of carbon dioxide (CO2) with respective emission/revenue ratios of 0.424 and 126.8[163]. - The Group's resource usage for the year ended June 30, 2024, includes 342,208 degrees of electricity, 38,216 liters of petrol, and 1,745 m³ of water, with usage/revenue ratios of 481.0, 53.7, and 2.5 respectively[177]. - The Group actively promotes energy-saving and emission reduction measures among its manufacturers, ensuring compliance with national environmental protection regulations[165]. - The Group has reduced business trips to lower energy consumption and greenhouse gas emissions, utilizing teleconferencing as an alternative[164]. - The Group's commitment to environmental protection includes a "green office" initiative aimed at saving electricity and water through employee awareness and behavior changes[170]. - The Group's policies for energy and water conservation provide specific guidance to employees on reducing environmental impact[179]. - The Group's transportation strategy prioritizes local suppliers to minimize energy consumption during the transportation process[158]. - The Group's environmental initiatives include promoting electronic documentation to reduce paper usage and implementing a paperless office policy[171]. Employee Management and Training - As of June 30, 2025, the Group had 842 employees, with 99.0% located in mainland China[185]. - The employee turnover rate for general staff aged 50 and above was 38.5%, while for those aged 40-49 it was 40.2%[196]. - The Group's management has implemented strict compliance with local employment laws, ensuring fair treatment regardless of nationality, race, gender, or age[186]. - The Group provides environmental protection training for new employees and actively promotes green purchasing practices[181]. - The Group's compensation structure links a portion of employee pay to individual and overall performance, incentivizing high performance[189]. - The Group has a zero-tolerance policy for child labor and forced labor, conducting strict recruitment examinations to prevent such practices[188]. - The Group has established management policies and procedures for human resources to ensure an ideal and safe working environment for employees[198]. - The Group implements national regulations on occupational safety and provides necessary labor protection resources, including white gowns for sales personnel[199]. - Regular monitoring of compliance status is conducted, including checks on fire-fighting equipment and air quality maintenance[199]. - The Group provides social insurance for employees, including employment injury insurance, and liability insurance for directors and senior management[199]. Strategic Initiatives and Future Plans - The Group plans to divest non-primary businesses and optimize store layout to adapt to the competitive pharmaceutical market[37]. - The "Specialization+" strategy will be implemented to improve service professionalism and operational quality, leveraging licensed pharmacists and business institute advantages[134][136]. - The "Platform+" strategy aims to expand value-added services in stores to meet increasing consumer health demands, adapting to new market conditions[137]. - The "Internet+" strategy will strengthen the integration of online and offline services, utilizing mobile internet technologies and e-commerce partnerships[139][140]. - A subscription agreement was entered into on May 13, 2025, for 30,440,263 new shares at HK$0.80 per share, raising approximately HK$24.35 million[141][142]. - The company plans to enhance the integration of online and offline operations through its "Internet+" strategy, leveraging mobile internet applications and new marketing ecosystems[143]. - A total of 30,440,263 new shares were issued at a subscription price of HK$0.80 per share, raising approximately HK$24.35 million[144]. - The authorized share capital will increase from US$10 million to US$50 million, allowing for greater flexibility in future fundraising efforts[146]. - The increase in authorized share capital was approved by shareholders on August 19, 2025, and became effective the same day[147].

Investment Strategy - The Group has adopted a cautious investment strategy, with no new significant external investment plans as of the 2024 annual report date[5]. - The Group has implemented effective risk control measures for existing investments and is actively seeking exit or refinancing opportunities to realize investment returns[5]. - The investment in Boya Zhongke is a strategic investment aimed at generating business synergies within the industry chain[6]. - The Group maintains a prudent financial management strategy, opting for low-risk, high-liquidity financial products[5]. Financial Performance - As of December 31, 2024, the Group's investment in Boya Zhongke accounted for 5% of the total assets, with an investment cost of RMB 66.7 million and a fair value of RMB 71.6 million[4]. - The investment in structured deposits amounted to RMB 100.0 million, with a fair value of RMB 100.7 million, yielding a return of RMB 8.28 million during the reporting period[6]. - The Group's total assets remained stable with no significant changes reported during the period[4]. Acquisitions and Disposals - The Group has not made any significant acquisitions or disposals of subsidiaries or associated companies during the reporting period[7]. - The Group's investment in Boya Zhongke was accounted for using the equity method during the reporting period[6]. Miscellaneous - All other information in the 2024 annual report remains unchanged[8].

Financial Performance - The company's operating revenue for the third quarter reached ¥1,865,909,777.54, representing a year-on-year increase of 12.91%[10] - Net profit attributable to shareholders was ¥210,505,861.11, a significant increase of 172.65% compared to the same period last year[10] - The basic earnings per share for the quarter was ¥0.15, reflecting a growth of 150.00% year-on-year[10] - The company's operating revenue reached 5.373 billion yuan, a year-on-year increase of 7.16%, with core business revenue at 4.899 billion yuan, up 12.59%[32] - Gross profit margin improved to 19.49%, an increase of 9.46 percentage points compared to the same period last year[32] - Net profit attributable to shareholders was 515 million yuan, a significant year-on-year growth of 161.81%, while net profit excluding non-recurring gains and losses surged by 381.94% to 430 million yuan[32] - Operating profit significantly increased to ¥571,753,894.77, up from ¥220,314,294.24, marking a growth of 159.5%[41] - Net profit for the current period was ¥524,281,832.36, compared to ¥200,571,833.10 in the previous period, representing a growth of 161.5%[41] - Total comprehensive income for the current period reached approximately ¥533 million, a significant increase from ¥173 million in the previous period, representing a growth of 207%[43] Assets and Liabilities - Total assets at the end of the reporting period amounted to ¥14,719,678,270.37, marking a 19.70% increase from the previous year[10] - The company's equity attributable to shareholders increased to ¥7,222,950,788.55, up by 2.95% compared to the end of the previous year[10] - Total liabilities increased to ¥7,385,932,565.59 from ¥5,179,863,454.31, a rise of 42.7%[38] - Current liabilities due within one year increased significantly by 6,719.88% to approximately $685.16 million, primarily due to the increase in large certificates of deposit maturing within the reporting period[16] - Total current assets increased to approximately 10.288 billion yuan from 7.692 billion yuan at the beginning of the period[35] Cash Flow - The company reported a cash flow from operating activities of -¥199,007,204.06, indicating a significant decline of 196.10%[10] - Operating cash flow net amount decreased by 196.10% to approximately -$199.01 million, mainly due to increased procurement of raw materials[19] - Cash inflow from investment activities totaled approximately ¥872 million, while cash outflow was around ¥1.52 billion, resulting in a net cash outflow of approximately ¥648 million[47] - Cash inflow from financing activities was approximately ¥2.35 billion, with a net cash inflow of about ¥1.69 billion after accounting for cash outflows[48] Shareholder Information - The total number of common shareholders at the end of the reporting period was 134,044[20] - The largest shareholder, Jiangxi Ruide Venture Capital Co., Ltd., holds 28.29% of the shares, amounting to 387,100,160 shares[21] - HKSCC Nominees Limited holds 227,640,800 shares, indicating strong foreign investment interest in the company[24] - The company reported a 0.93% shareholding by Industrial and Commercial Bank of China, reflecting diverse institutional investment[24] - The company has a total of 2,550,720 shares under lock-up conditions due to executive resignation, which may impact future share liquidity[28] Operational Developments - The company has established a new business unit focused on rubber soft magnetic materials, investing in a fully automated production line to enhance its product offerings[31] - The company aims to provide a full range of magnetic material solutions, integrating existing products with new developments to create greater value for customers[30] - The company has delivered small batches of products in the fields of embodied robotics and low-altitude drones, indicating progress in new technology applications[31] - The management team is committed to stable and compliant operational strategies, focusing on market expansion through technological innovation and organizational optimization[29] - The company has established long-term stable partnerships with leading enterprises in various fields, enhancing its market position[29] Research and Development - Research and development expenses grew by 37.31% to approximately $315.88 million, attributed to increased raw material costs for R&D[18] - Research and development expenses increased to ¥315,878,525.67, up from ¥230,044,877.75, reflecting a growth of 37.2%[40] Market Performance - Sales revenue from the new energy vehicle and auto parts sector reached 2.615 billion yuan, with a corresponding sales volume increase of 23.46%[32] - The energy-saving variable frequency air conditioning sector generated sales revenue of 1.446 billion yuan, reflecting an 18.48% year-on-year growth in sales volume[32] - Overseas sales revenue amounted to 942 million yuan, accounting for 17.54% of total operating revenue, remaining stable compared to the previous year[32] - Sales revenue from exports to the United States was 354 million yuan, representing a year-on-year increase of 43.92%[32] - The company has sufficient orders on hand for the fourth quarter, indicating strong demand and operational stability[32] - The company has actively adjusted its raw material inventory strategy to mitigate risks associated with fluctuations in rare earth material prices, ensuring delivery capabilities[32] Government Support - The company received government subsidies amounting to ¥21,346,341.01, contributing positively to its financial performance[12]

ISP Global Limited (於開曼群島註冊成立的有限公司) 股份代號：8487 2024/25 年 報 ISP Global Limited (incorporated in the Cayman Islands with limited liability) Stock Code: 8487 ANNUAL O RT 2 REPORT 2024/25 ISP Global Limited A N N U AL RE P 0 2 4 /25 年報 香港聯合交易所有限公司（「聯交所」）GEM的特色 GEM的定位，乃為相比起其他在聯交所上市的公司帶有較高投資風險的中小型公司提供一個上市的市場。 有意投資人士應了解投資於該等公司的潛在風險，並應經過審慎周詳的考慮後方作出投資決定。 由於GEM上市公司普遍為中小型公司，在GEM買賣的證券可能會較於聯交所主板買賣的證券承受較大的市 場波動風險，同時無法保證在GEM買賣的證券會有高流通量的市場。 香港交易及結算所有限公司及聯交所對本報告的內容概不負責，對其準確性或完整性亦不發表任何聲明， 並明確表示概不就因本報告全部或任何部分內容而產生或因倚賴該等內容而引致的任 ...